Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because evolution can be visualized in rea...
Background and rational. Telaprevir-based therapy (TBT) has been extensively evaluated in clinical trials. So we designed a study to compare the efficacy and safety of TBT between patients with moderate fibrosis and thos...
For the last decade, the combination therapy of pegylated interferon (Peg-IFN) plus ribavirin (RBV) hasbeen considered as the standard of care treatment for chronic hepatitis C virus (HCV) infection. However, it has been...
Pentoxifylline and prednisolone in severe alcoholic hepatitis
The effect of ursodeoxycholic acid in cystic cholangiopathies
Inter and intrapatient evolution of hepatitis C virus
Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because evolution can be visualized in rea...
High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain
Background and rational. Telaprevir-based therapy (TBT) has been extensively evaluated in clinical trials. So we designed a study to compare the efficacy and safety of TBT between patients with moderate fibrosis and thos...
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
For the last decade, the combination therapy of pegylated interferon (Peg-IFN) plus ribavirin (RBV) hasbeen considered as the standard of care treatment for chronic hepatitis C virus (HCV) infection. However, it has been...